Hippocampal BMP signaling as a common pathway for antidepressant action
Authors:
- 22 December 2021
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (1) , 1-18
Abstract
The benefits of current treatments for depression are limited by low response rates, delayed therapeutic effects, and multiple side effects. Antidepressants affect a variety of neurotransmitter systems in different areas of the brain, and the mechanisms underlying their convergent effects on behavior have been unclear. Here we identify hippocampal bone morphogenetic protein (BMP) signaling as a common downstream pathway that mediates the behavioral effects of five different antidepressant classes (fluoxetine, bupropion, duloxetine, vilazodone, trazodone) and of electroconvulsive therapy. All of these therapies decrease BMP signaling and enhance neurogenesis in the hippocampus. Preventing the decrease in BMP signaling blocks the effect of antidepressant treatment on behavioral phenotypes. Further, inhibition of BMP signaling in hippocampal newborn neurons is sufficient to produce an antidepressant effect, while chemogenetic silencing of newborn neurons prevents the antidepressant effect. Thus, inhibition of hippocampal BMP signaling is both necessary and sufficient to mediate the effects of multiple classes of antidepressants.Keywords
Funding Information
- National Institute of Mental Health (R01 MH114923)
- Davee Foundation
This publication has 69 references indexed in Scilit:
- Re-cycling Paradigms: Cell Cycle Regulation in Adult Hippocampal Neurogenesis and Implications for DepressionMolecular Neurobiology, 2013
- Remote Control of Neuronal SignalingPharmacological Reviews, 2011
- Imipramine Treatment Improves Cognitive Outcome Associated with Enhanced Hippocampal Neurogenesis after Traumatic Brain Injury in MiceJournal of Neurotrauma, 2011
- Antidepressants recruit new neurons to improve stress response regulationMolecular Psychiatry, 2011
- A chemical-genetic approach to study G protein regulation of β cell function in vivoProceedings of the National Academy of Sciences, 2009
- BMP Signaling Mediates Effects of Exercise on Hippocampal Neurogenesis and Cognition in MicePLOS ONE, 2009
- Antidepressants increase neural progenitor cells in the human hippocampusNeuropsychopharmacology, 2009
- Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/DepressionNeuron, 2009
- Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant ReversalBiological Psychiatry, 2008
- Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandProceedings of the National Academy of Sciences, 2007